| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/10/2007 | WO2007030574A3 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| 05/10/2007 | WO2007025897A3 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 05/10/2007 | WO2007020286A3 Method of using potassium channel inhibiting compounds |
| 05/10/2007 | WO2007016108B1 Compositions for affecting weight loss |
| 05/10/2007 | WO2007014895A3 Methods for preventing and treating metabolic disorders and new pyrazole-o-glycoside derivatives |
| 05/10/2007 | WO2007006751A3 Use of bpi protein for the treatment of disorders of the metabolism and cardiovascular disorders |
| 05/10/2007 | WO2006130775A3 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
| 05/10/2007 | WO2006129095A3 Sustained release preparations of pro-insulin c-peptide |
| 05/10/2007 | WO2006128058A3 Thyromimetics for the treatment of fatty liver diseases |
| 05/10/2007 | WO2006069363A3 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 05/10/2007 | US20070106076 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles |
| 05/10/2007 | US20070105961 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
| 05/10/2007 | US20070105910 Medicinal composition |
| 05/10/2007 | US20070105901 Novel piperidine derivative |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105894 Combination of at least two compounds selected from an AT1-receptorantagonist or an ACE inhibitor or a HMG-Co-A reductase inhibitor |
| 05/10/2007 | US20070105890 Novel condensed imidazole derivative |
| 05/10/2007 | US20070105889 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for therapy of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea |
| 05/10/2007 | US20070105883 Novel physiologically active substances pf127oa, b and c substances |
| 05/10/2007 | US20070105882 Polymorphic forms of a known antihyperlipemic agent |
| 05/10/2007 | US20070105868 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105856 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism |
| 05/10/2007 | US20070105853 2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/10/2007 | US20070105846 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 05/10/2007 | US20070105843 Combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 05/10/2007 | US20070105837 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2][2]-benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 05/10/2007 | US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide |
| 05/10/2007 | US20070105818 Water solubility, bioavailability, oral administration; unit dosage |
| 05/10/2007 | US20070105759 Melanocortin receptor 4 (mc4) agonists and their uses |
| 05/10/2007 | US20070104781 Hypocholesteremic preparations containing mixtures of phytostenol(ester)s and conjugated fatty acids, and methods of using the same |
| 05/10/2007 | US20070104702 Method for treating diseases associated with changes of qualitative and/quantitative composition of blood extracellular dna |
| 05/10/2007 | CA2628486A1 Tricyclo substituted amides |
| 05/10/2007 | CA2628274A1 Glucokinase activators |
| 05/10/2007 | CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/10/2007 | CA2627910A1 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627892A1 Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627307A1 Pharmaceutical use of substituted amides |
| 05/10/2007 | CA2627306A1 Pharmaceutical use of substituted amides |
| 05/10/2007 | CA2626504A1 Tricyclo substituted amides as glucokinase modulators |
| 05/09/2007 | EP1783136A1 Lipase inhibitor |
| 05/09/2007 | EP1783127A1 Novel compound having lipase inhibitory activity |
| 05/09/2007 | EP1783124A1 2-phenylthiophene derivative |
| 05/09/2007 | EP1783113A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 05/09/2007 | EP1782859A2 Pharmaceutical use of substituted pyrazolo [1,5- a]pyrimidines |
| 05/09/2007 | EP1782832A1 Remedy for diabetes |
| 05/09/2007 | EP1782829A1 Preventive and/or remedy for hyperkalemia containing ep4 agonist |
| 05/09/2007 | EP1782828A1 Progression inhibitor for disease attributed to abnormal accumulation of liver fat |
| 05/09/2007 | EP1782825A2 Treatment of glycogen storage diseases type II |
| 05/09/2007 | EP1782813A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 05/09/2007 | EP1782805A1 Composition for accelerating calcium absorption |
| 05/09/2007 | EP1782803A1 Coenzyme q10-containing composition |
| 05/09/2007 | EP1781663A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/09/2007 | EP1781659A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 05/09/2007 | EP1781656A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/09/2007 | EP1781645A1 Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 05/09/2007 | EP1781633A1 Novel antidiabetic compounds |
| 05/09/2007 | EP1781608A1 Indole derivatives comprising an acetylene group as ppar activators |
| 05/09/2007 | EP1781607A2 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 05/09/2007 | EP1781324A2 Pharmaceutically active insulin receptor-modulating molecules |
| 05/09/2007 | EP1781322A1 Method for treating diabetes |
| 05/09/2007 | EP1781282A1 Composition for stabilizing vitamin c in water phase and method for stabilizing vitamin c using thereof |
| 05/09/2007 | EP1781279A2 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders |
| 05/09/2007 | EP1781271A1 Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases |
| 05/09/2007 | EP1781116A1 Natural sweetener |
| 05/09/2007 | EP1487469A4 Co-beadlet of dha and rosemary and methods of use |
| 05/09/2007 | EP1406883B1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3) |
| 05/09/2007 | EP1355542B1 Nutritional composition with health promoting action containing oligosaccharides |
| 05/09/2007 | EP1338651B9 Method of screening remedy for diabetes |
| 05/09/2007 | EP1265907B9 Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1183245B1 Selective npy (y5) antagonists |
| 05/09/2007 | EP1180143B1 In vitro methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues, pharmaceutical compositions related thereto |
| 05/09/2007 | EP1166652B1 Utilization of material containing docosapentaenoic acid |
| 05/09/2007 | CN1960989A Substituted oxazolobenzoisothiazole dioxide derivatives, production method and use thereof |
| 05/09/2007 | CN1960977A Quinazoline derivative |
| 05/09/2007 | CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof |
| 05/09/2007 | CN1960735A Use of drug combinations for treating insulin resistance |
| 05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
| 05/09/2007 | CN1960725A Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis |
| 05/09/2007 | CN1960723A Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight |
| 05/09/2007 | CN1960722A Use of furan alkyl for preparing an antidiabetic drug |
| 05/09/2007 | CN1960717A Composition for capsule film, capsule film, and capsule made with the same |
| 05/09/2007 | CN1958617A Tea polysaccharide, preparation method, and usage |
| 05/09/2007 | CN1958035A Composition of medication in use for reducing blood sugar, blood fat, and treating diabetes |
| 05/09/2007 | CN1958013A Medication or foodstuff with effects of lowering blood sugar, and improving sexual function |
| 05/09/2007 | CN1958000A Method for processing rhizoma coptidis |
| 05/09/2007 | CN1957992A Method for preparing extractive of plant of containing sequoyitol, and pharmaceutical usage |
| 05/09/2007 | CN1957988A Preparation method for separating and purifying extractive from lotus leaves, and usage |
| 05/09/2007 | CN1957971A Health products for decreasing blood fat |
| 05/09/2007 | CN1957964A Method for preparing extractive of Jumi |
| 05/09/2007 | CN1957958A Method for preparing extractive of ginkgo leaves |